# Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. is a company headquartered in Foster City, CA, United States.

## Company overview

- **Legal name:** Terns Pharmaceuticals, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Foster City, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001831363

## About

Terns Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001831363, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-30, it reported net income of USD -96,207,000; total assets of USD 1,025,078,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Net income:** -$96.2M (USD -96,207,000)
- **Total assets:** $1.0B (USD 1,025,078,000)
- **Cash and equivalents:** $524.7M (USD 524,747,000)
- **Operating cash flow:** -$82.2M (USD -82,176,000)

### FY2024 (period ended 2024-12-31)

- **Net income:** -$88.9M (USD -88,853,000)
- **Total assets:** $363.9M (USD 363,929,000)
- **Cash and equivalents:** $161.4M (USD 161,439,000)
- **Operating cash flow:** -$70.0M (USD -70,016,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$90.2M (USD -90,210,000)
- **Total assets:** $268.5M (USD 268,517,000)
- **Cash and equivalents:** $79.9M (USD 79,926,000)
- **Operating cash flow:** -$67.4M (USD -67,390,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$60.3M (USD -60,345,000)
- **Total assets:** $287.0M (USD 287,026,000)
- **Cash and equivalents:** $143.2M (USD 143,235,000)
- **Operating cash flow:** -$49.1M (USD -49,109,000)

## Recent SEC filings

- Form 8-K — filed 2026-05-05 — period 2026-05-05 — 8-K
- Form 10-K/A — filed 2026-04-27 — period 2025-12-31 — 10-K/A
- Form 8-K — filed 2026-04-27 — period 2026-04-27 — 8-K
- Form 10-K — filed 2026-03-30 — period 2025-12-31 — 10-K
- Form 8-K — filed 2026-03-25 — period 2026-03-24 — 8-K
- Form 8-K — filed 2026-01-22 — period 2026-01-16 — 8-K
- Form 8-K — filed 2026-01-09 — period 2026-01-07 — 8-K
- Form 8-K — filed 2025-12-11 — period 2025-12-09 — 8-K
- Form 8-K — filed 2025-12-08 — period 2025-12-08 — 8-K
- Form 10-Q — filed 2025-11-10 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-11-10 — period 2025-11-10 — 8-K
- Form 8-K — filed 2025-11-03 — period 2025-11-03 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/terns-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology